Skip to main content

Table 1 The timeline of clinical indicators levels relative to treatment

From: C3 glomerulonephritis along with light chain proximal tubulopathy without crystal deposits in multiple myeloma: a case report

Time

Scr (mmol/L)

24 h UTP (g/24 h)

C3 (g/L)

Serum-free lambda light chain (g/L)

Urine lambda light chain (g/L)

2017.11.15 BD

0.0606

0.13

0.047

8.05

0.517

2017.12.26 BD

0.0541

0.09

0.058

5.05

0.005

2018.01.22 BD

0.0563

0.14

0.632

3.11

0.005

2018.02.20 BD

0.0581

0.16

0.661

1.55

0.005

2018.04.10 CTX*

0.0605

0.15

0.258

3.67

0.005

2018.06.19 PAD

0.0668

0.16

0.189

3.71

0.005

2018.09.04 after autoHCT

0.0572

0.14

0.175

3.89

0.005

  1. Abbreviations: Scr serum creatinine, 24 h UTP 24-h urinary protein quantity, BD bortezomib plus dexamethasone, CTX* mobilisation with cyclophosphamide, PAD bortezomib plus doxorubicin and dexamethasone, autoHCT autologous stem cell transplantation